(Q38765239)

6 September 2017

title

Schizophrenia: genetics, prevention and rehabilitation (English)

1 reference

6 September 2017

1 reference

Paolo Olgiati

1

0 references

Cristina Lorenzi

object named as

Cristina Lorenzi

3

0 references

Alessandro Serretti

object named as

Alessandro Serretti

8

0 references

Laura Mandelli

2

object named as

Laura Mandelli

1 reference

6 September 2017

Elena Marino

4

1 reference

6 September 2017

Pirovano Adele

5

1 reference

6 September 2017

Barbara Ferrari

6

1 reference

6 September 2017

Diana De Ronchi

7

1 reference

6 September 2017

publication date

1 June 2009

1 reference

6 September 2017

published in

Acta Neuropsychiatrica

1 reference

6 September 2017

volume

21

1 reference

6 September 2017

issue

3

1 reference

6 September 2017

page(s)

109-120

1 reference

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Family Interaction and Communication Deviance in Disturbed and Normal Families: A Review of Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

White matter and cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Schizophrenia and viral infection during neurodevelopment: a focus on mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Schizophrenia endophenotypes as treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The endophenotype concept in psychiatry: etymology and strategic intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Genotype-environment interaction in schizophrenia-spectrum disorder. Long-term follow-up study of Finnish adoptees.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: Methods and power analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Are communication deviance and expressed emotion related to family history of psychiatric disorders in schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A critical review of genetic studies of schizophrenia. I. Epidemiological and brain studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Stressful life events preceding the first onset of psychosis. An explorative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Heritability estimates for psychotic disorders: the Maudsley twin psychosis series

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

"A gene for...": the nature of gene action in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Linkage analysis of psychosis in bipolar pedigrees suggests novel putative loci for bipolar disorder and shared susceptibility with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The myelin-pathogenesis puzzle in schizophrenia: a literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Molecular genetics of schizophrenia: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Models for the joint effect of genotype and environment on liability to psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Stress-reactivity in psychosis: evidence for an affective pathway to psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Emotional reactivity to daily life stress in psychosis and affective disorder: an experience sampling study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Life events can trigger depressive exacerbation in the early course of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Heterozygous neuregulin 1 mice are more sensitive to the behavioural effects of Delta9-tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Precipitation and determination of the onset and course of schizophrenia by substance abuse--a retrospective and prospective study of 232 population-based first illness episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Double jeopardy: schizophrenia and substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Patterns of current and lifetime substance use in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Reduction of symptoms by valacyclovir in cytomegalovirus-seropositive individuals with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Antibodies to infectious agents in individuals with recent onset schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Cytomegalovirus and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Human influenza viral infection in utero alters glial fibrillary acidic protein immunoreactivity in the developing brains of neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Oxygen restriction of neonate rats elevates neuregulin-1alpha isoform levels: possible relationship to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Obstetric conditions and risk of first admission with schizophrenia: a Danish national register based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The promoter -194 C polymorphism of the nicotinic alpha 7 receptor gene has a protective effect against the P50 sensory gating deficit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The genetics of sensory gating deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Prenatal viral infection causes alterations in nNOS expression in developing mouse brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The Glutamatergic Dysfunction Hypothesis for Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Genetic variation in DTNBP1 influences general cognitive ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Early visual processing deficits in dysbindin-associated schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The dystrobrevin-binding protein 1 gene: features and networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A haplotype within the DISC1 gene is associated with visual memory functions in families with a high density of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A single nucleotide polymorphism fine mapping study of chromosome 1q42.1 reveals the vulnerability genes for schizophrenia, GNPAT and DISC1: Association with impairment of sustained attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL: regulation and loss of interaction with mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Disrupted-In-Schizophrenia 1 regulates integration of newly generated neurons in the adult brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex: implications for schizophrenia and other major neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A review of Disrupted-In-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Disruption of two novel genes by a translocation co-segregating with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Meta-analysis reveals no association of the Val66Met polymorphism of brain-derived neurotrophic factor with either schizophrenia or bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Role of the reelin signaling pathway in central nervous system development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

BDNF regulates reelin expression and Cajal-Retzius cell development in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

State of the art of the neurotrophin hypothesis in psychiatric disorders: implications and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population level

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The neuregulin-I/ErbB signaling system in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Neuregulins: functions, forms, and signaling strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Influence of catechol-O-methyltransferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Is it time to develop a new cognitive therapy for psychosis--cognitive remediation therapy (CRT)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A meta-analysis of cognitive remediation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Cognitive remediation in schizophrenia: is it time yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The effects of second-generation antipsychotics on cognitive functioning and psychosocial outcome in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A quantitative association study between schizotypal traits and COMT, PRODH and BDNF genes in a healthy Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158Met genotype and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Catechol-O-methyltransferase Val158Met polymorphism in schizophrenia: associations with cognitive and motor impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Effect of COMT Val158Met polymorphism on the Continuous Performance Test, Identical Pairs Version: tuning rather than improving performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Performance on the Wisconsin Card Sorting Test in schizophrenia and genes of dopaminergic inactivation (COMT, DAT, NET).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Cognitive effects and antipsychotic treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Treatment of cognitive dysfunction in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Patient outcomes in schizophrenia II: the impact of cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Disorganization syndrome is correlated to working memory deficits in unmedicated schizophrenic patients with recent onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Working memory correlates of three symptom clusters in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Executive attention in schizophrenic males and the impact of COMT Val108/158Met genotype on performance on the attention network test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Catechol O-methyl transferase and dopamine D2 receptor gene polymorphisms: evidence of positive heterosis and gene-gene interaction on working memory functioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

P50 sensory gating ratios in schizophrenics and controls: a review and data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Reduced P50 auditory gating response in psychiatrically normal chronic marihuana users: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The empirical status of the ultra high-risk (prodromal) research paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Early-onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Correlation of auditory 'oddball' P300 with verbal memory deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

P50 abnormalities in schizophrenia: relationship to clinical and neuropsychological indices of attention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Schizophrenia: from phenomenology to neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

A meta-analysis of cognitive deficits in adults with a diagnosis of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Gene-environment interaction in vulnerability to schizophrenia: findings from the Finnish Adoptive Family Study of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

The role of oligodendrocyte pathology in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Early and late environmental risk factors for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Executive Function in Patients with Remitted Bipolar Disorder and Schizophrenia and Its Relationship with Functional Outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Evidence that specific executive functions predict symptom variance among schizophrenia patients with a predominantly negative symptom profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1601-5215.2009.00360.X

10.1111/J.1601-5215.2009.00360.X

21 January 2018

Identifiers

DOI

1 reference

6 September 2017

1 reference